Navigation Links
Dewan Suprapubic Urodynamics Catheter Set

ProductsDewan Suprapubic Urodynamics Catheter Set
Company Cook Urological
Item Dewan Suprapubic Urodynamics Catheter Set
Features 
  • Used for suprapubic monitoring of bladder pressures.
  • Suprapubic urodynamic studies avoid the effects of urethral catheterization and eliminate the need for a double bladder puncture.
Description Used for suprapubic monitoring of bladder pressures. Suprapubic urodynamic studies avoid the effects of urethral catheterization and eliminate the need for a double bladder puncture. Supplied sterile in peel-open packages. Intended for one-time use.
Info Cook Urological
Customer Service: (800) 457-4448
Web site: http://www.cookurological.com/

Related medicine products :

1. OBrien Suprapubic Peel-Away® Access Set
2. Stamey Percutaneous Suprapubic Catheter Sets
3. Rutner Percutaneous Suprapubic Balloon Catheter Sets
4. OM-5 Lite Urodynamics System
5. OM-5 Lite Urodynamics System with EMG
6. OM-5 Lite Urodynamics System with CO2
7. OM™-5 Plus Urodynamics System with EMG and CO2
8. OM-5 Plus Urodynamics System
9. OM-5 Elite Urodynamics System with EMG
10. TRITON™ Wireless Urodynamics Systems with optional video
11. OM-5 Elite Urodynamics System with EMG and CO2
The LCS complete knee offers grit-blast textured components for cemented implantation and POROCOAT Porous Coated patellar, femoral and tibial components for cementless fixation.
...ak system includes a cruciate sparing version whic...th both resurfacing and inset patellas. Precision ...atics and fit with tibial articular surface and pa...ocations provide easy intraoperative change of siz...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i
Medicine Products:
(Date:8/29/2008)..., Aug. 29 /PRNewswire/ -- In response to recent ne...ic wasting disease (CWD),members of the deer farm..., With hunting season fast approaching, the tragi...r on a Kent County farm understandably has,created...er farmers across,the great state of Michigan. The...
(Date:8/29/2008)...ntific obligation reduced from $250 to $19 million...- Boston Scientific,Corporation (NYSE: BSX ) toda...ll, Texas found two patents of Medtronic, Inc. (NY...uring the prosecution of the patents,before the Un...had previously found that certain Boston Scientifi...
(Date:8/29/2008)... Allsup explains financial implications of ...rs available to people with disabilities. , ... 29, 2008 -- Deciding how to move forward after a ...matter, but it,s important that individuals do as ...ions, according to http://www.allsup.com/ [Allsu...
(Date:8/28/2008)...even after conventional therapy, study found , ...king out on a treadmill improves brain function an...d gone through the usual rehabilitation program, a...hese patients have," said study researcher Dr. And...eurorehabilitation at the University of Zurich in ...
Breaking Medicine News(10 mins):Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Treadmill Workouts Help Stroke Survivors 2
...esearchers at the Virginia Bioinformatics Institut...sts to have a better //understanding of the metabo...(azidothymidine, AZT). AZT is used successfully a...Therapy (HAART) to control the level of the human ...
...ess or craw craw is endemic to Bioko Island, Equat.../ in affected individuals thus rendering them list...impacts the economy of this area. The disease is c...ted through the bite of the black fly, Simulium. &...
...sychology showed that men find heavier women more ...who wanted to test their theory linking appetite a... that hungry men preferred heavier women. Dr Vir...artment of Public Health and Dr Martin Tovee from ...
...l conducted by researchers at St. Jude Children's ...of erythropoietin //(EPO) is a very effective trea...op anemia during chemotherapy. EPO is a natural h...moglobin. It reduces the need for red blood cell ...
Other Medicine News:Health News:Computational Model Reveals Working of AZT in Body 2Health News:Onchocerciasis: Presentation And Treatment 2Health News:EPO Effective For Cancer Patients Suffering From Anemia 2
(Date:8/27/2008)... - Patients in the VELCADE, melphalan and predni...efit as well as a 30 percent complete response -, ...ium: The Takeda,Oncology Company today announced t...ndomized, Phase III VISTA(1) trial in this week,s ...e results showed a significant survival,benefit an...
(Date:8/27/2008)... Nationally Recognized Pediatric Heart Center at T...ccess for Community to Complete Range of Care and ...wly Recruited Pediatric Cardiology Team Treats Eve...-USNewswire/ -- The Children,s Hospital at,Montefi...atric heart,transplantation to the Bronx, followin...
(Date:8/26/2008)... Company to present data from landmark SYNT...wire-FirstCall/ -- Boston Scientific,Corporation (...ompany,s major,events and press announcements at t...hich runs from August 30 to September 3 in Munich,... data from the SYNTAX trial,which compares percut...
(Date:8/26/2008)... Study finds most patients can drive safely six...l., Aug. 26 /PRNewswire-USNewswire/ -- Six weeks f...s are so low that they are able to,get back behind...e August,2008 issue of The Journal of Bone and Joi...t emergency brake time response in patients who un...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4Braking After Bunion Surgery 2Braking After Bunion Surgery 3ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 6963 1ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 6963 2ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 6963 3Ben Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia 25022 1Ben Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia 25022 2Ortho Biotech Announces Nationwide Voluntary Recall of Procrit 28R 29 28Epoetin Alfa 29 Lot Number P114942A 6962 1Ortho Biotech Announces Nationwide Voluntary Recall of Procrit 28R 29 28Epoetin Alfa 29 Lot Number P114942A 6962 2Replidyne Announces Second Quarter 2008 Results From Operations 6959 1Replidyne Announces Second Quarter 2008 Results From Operations 6959 2Replidyne Announces Second Quarter 2008 Results From Operations 6959 3Replidyne Announces Second Quarter 2008 Results From Operations 6959 4Replidyne Announces Second Quarter 2008 Results From Operations 6959 5Replidyne Announces Second Quarter 2008 Results From Operations 6959 6Replidyne Announces Second Quarter 2008 Results From Operations 6959 7
... Maintained for at Least 24 Weeks, According,to Re...May 15, 2007 /PRNewswire/ -- Researchers from Guy,...icine have,announced the results from the first ra...valuating botulinum toxin type A (BTX-A,BOTOX(R))...ty (IDO),in patients with symptoms of overactive b...
...S WIRE)--May 17, 2007 - Pro-Pharmaceuticals,Inc. ...carbohydrate,compounds today announced that Elieze...Development and Manufacturing will present,"Pharm...umors of,5-FU with an Admixture of a Galactomannan...developmental Biology and Medicine,(ISOBM) Confere...
Other Medicine Technology:First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 2First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 3First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 2Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 3Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 5